Related Experiment Video
Updated: Jul 5, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Patient Perspectives on Clotting in the Extracorporeal Circuit and Decision-Making Regarding Anticoagulation Therapy
Chandana Guha1, Daniel Gallego2, Amanda Grandinetti3
1Centre for Kidney Research, Children's Hospital at Westmead, Sydney, Australia; Sydney School of Public Health, University of Sydney, Sydney, Australia.
Insights
Understanding patient priorities in hemodialysis anticoagulation therapy is crucial. Shared decision-making can improve treatment adherence and outcomes for patients experiencing extracorporeal circuit clotting.
Area of Science:
- Nephrology
- Hematology
- Patient Care
Background:
- Extracorporeal circuit clotting is a significant complication during hemodialysis, leading to treatment interruptions and adverse patient outcomes.
- Inadequate dialysis due to clotting can cause blood loss, fluid overload, mineral imbalances, increased hospitalizations, and reduced quality of life.
- Anticoagulation therapy is vital for maintaining dialysis circuit patency and ensuring treatment adequacy.
Purpose of the Study:
- To explore patients' perspectives and priorities regarding clotting and anticoagulation therapy in hemodialysis.
- To identify strategies for supporting patients through shared decision-making in managing thrombotic complications.
- To inform improved care strategies and patient outcomes in hemodialysis.
Main Methods:
- Qualitative exploration of patient experiences and decision-making processes related to anticoagulation.
- Discussion of patient priorities in the context of extracorporeal circuit clotting.
- Analysis of insights to inform shared decision-making models.
Main Results:
- Patient perspectives on anticoagulation therapy and clotting are not well understood.
- Identifying patient priorities is key to effective anticoagulation management.
- Shared decision-making can enhance patient engagement and treatment success.
Conclusions:
- Understanding patient viewpoints on anticoagulation is essential for optimizing hemodialysis care.
- Shared decision-making empowers patients and can mitigate the impact of clotting complications.
- Incorporating patient priorities into treatment plans can improve hemodialysis adequacy and quality of life.
Abstract:
Clotting of the extracorporeal circuit is a complication in the process of hemodialysis that can result in missed or shortened dialysis sessions, higher nursing workload, and elevated cost of treatment. Repercussions of inadequate dialysis may include patient blood loss, fluid overload, build-up of minerals, higher hospitalization rates, and poor quality of life, contributing to increased patient distress. Preventing clotting through anticoagulation therapy is the key to maintaining patency of the dialysis circuit and supporting dialysis adequacy. Despite the severe consequences of clotting in the extracorporeal circuit patients encounter, their perspectives on decision-making regarding anticoagulation therapy are not well known. In this article, we discuss patients' perspectives and priorities around clotting and anticoagulation therapy and outline ways to support their treatment through shared decision-making. Insights into patients' perspectives on addressing thrombotic complications of the extracorporeal circuit can inform strategies to improve care and outcomes for patients receiving hemodialysis.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

